Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.creator | Fernandez-Calderon, M. (M.) | - |
| dc.creator | Betes, M.T. (María Teresa) | - |
| dc.date.accessioned | 2014-03-04T08:06:25Z | - |
| dc.date.available | 2014-03-04T08:06:25Z | - |
| dc.date.issued | 2012 | - |
| dc.identifier.citation | Fernández Calderón M, Betés Ibáñez MT. Aspirina en la prevención primaria del cáncer colorrectal. An Sist Sanit Navar. 2012 May-Aug;35(2):261-7. | es_ES |
| dc.identifier.issn | 1137-6627 | - |
| dc.identifier.uri | https://hdl.handle.net/10171/35349 | - |
| dc.description.abstract | Aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) have been associated with a reduction in the risk of developing adenomas and colorectal cancer. The available scientific evidence justifies the need for more studies that evaluate the protective effect of aspirin and other NSAIDs as a preventive measure against cancer of the colon; define the minimum efficient dosage; the age at which to begin treatment; the most convenient duration of the latter; and the sub-populations for which the benefits of chemoprophylaxis outweigh possible adverse effects. | es_ES |
| dc.language.iso | spa | es_ES |
| dc.publisher | Gobierno de Navarra. Departamento de Salud | es_ES |
| dc.rights | info:eu-repo/semantics/openAccess | es_ES |
| dc.subject | Anti-Inflammatory Agents, Non-Steroidal/therapeutic use | es_ES |
| dc.subject | Colorectal Neoplasms/prevention & control | es_ES |
| dc.subject | Aspirin/therapeutic use | es_ES |
| dc.title | La aspirina en la prevención primaria del cáncer colorrectal | es_ES |
| dc.title.alternative | Aspirin in the primary prevention of colorectal cancer | es_ES |
| dc.type | info:eu-repo/semantics/article | es_ES |
| dc.identifier.pmid | 22948427 | - |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.
